• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX15REC W/ 4L RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX15REC W/ 4L RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX15RE40C
Medical Device Problem Code Partial Blockage (1065)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/18/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.H6: component code: 525 - tube.Health effect - impact code: 2645 - no patient involvement.Health effect - clinical code: 4582 - no clinical, signs, symptoms or conditions.Medical device problem code: 1065 - partial blockage.Investigation findings: 3233 - results pending completion of investigation.Investigation conclusions: 11 - conclusion not yet available.
 
Event or Problem Description
The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during prime, there was a purge liquid outlet blockage in the sampling line.No patient involvement.The product was changed out.The surgery was completed successfully.
 
Event or Problem Description
Purge liquid outlet blockage in the sampling line.
 
Additional Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on august 11, 2023.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added expiration date).E1 (initial reporter - address, city and zip code).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H4 (device manufacture date).H6 (identification of evaluation codes 11, 3331, 4114, 170, 25).Type of investigation #1: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #2: 3331 - analysis of production records.Type of investigation #3: 4114 - device not returned.Investigation finding: 170 - manufacturing process problem identified.Investigation conclusions:25 - cause traced to manufacturing.The actual sample was not returned; however, a video was provided.After review of the video, it was confirmed that there was a partial blockage in the pigtail line as there was a slow drip of fluid coming from the line.A representative retention sample from the product lot was previously tested, and no anomalies were noted during testing.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Additional Manufacturer Narrative
The returned sample was inspected upon receipt to confirm that there was a partial blockage in the pigtail line as there was a slow drip of fluid coming from the line when di water was passed through.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Event or Problem Description
Purge liquid outlet blockage in the sampling line.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX15REC W/ 4L RES
Common Device Name
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
douglas patton
125 blue ball rd
elkton, MD 21921
7346634145
MDR Report Key17513433
Report Number1124841-2023-00198
Device Sequence Number20887141
Product Code DTZ
UDI-Device Identifier00699753450813
UDI-Public(01)00699753450813
Combination Product (Y/N)N
Initial Reporter CountryCO
PMA/510(K) Number
K151791
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2025
Device Model Number3CX*FX15RE40C
Device Catalogue NumberN/A
Device Lot Number2L19
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/24/2023
Supplement Date Received by Manufacturer09/06/2023
10/24/2023
Initial Report FDA Received Date08/11/2023
Supplement Report FDA Received Date09/20/2023
11/03/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/20/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age31 YR
Patient SexUnknown
Patient EthnicityHispanic
Patient RaceWhite
-
-